Erythropoietin Drug Global Market Key Developments, Outlook, 2016 Analysis & Forecast to 2022
ReportsWeb.com published “Erythropoietin Drug Global Market” from its database. This report Strategic recommendations in key business segments based on the market estimations. This report Supply chain trends mapping the latest technological advancements.
(EMAILWIRE.COM, April 15, 2017 ) According to Publisher, the Global Erythropoietin Drug Market is accounted for $8.04 billion in 2016 and is expected to reach $14.4 billion by 2022 growing at a CAGR of 10.2% from 2016 to 2022. Rising number of chronic kidney diseases (CKD) and dialysis patient pools are the major drivers for the market. Moreover, increasing cases of cancer, HIV's and ESRD (End Stage Renal Diseases) are some of the factors enhancing the market growth. However, growing competition from substitute drugs and rising threats from thrombosis and PRCA are the factors inhibiting the market size.
For more information about this report: http://www.reportsweb.com/erythropoietin-drug-global-market-outlook-2016-2022
By Application, anemia segment leads the Erythropoietin Drugs market during the forecast period. On the other hand, retail pharmacies in end user segment dominated the global market with a huge market share. In terms of geography, Europe commanded the maximum market share and will continue to dominate the market over the forecast period.
Some of the key players in the market include Johnson and Johnson, Hospira, Inc., F. Hoffmann-La Roche AG, Amgen Inc, Kyowa Hakko Kirin Co., Ltd, 3SBio Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Intas Pharmaceuticals, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries, JCR Pharmaceuticals, LG Life Science, Novartis AG, Shenyang Sunshine Pharmaceutical, Sihuan Pharmaceutical, Uni-Bio Science, Wanbang Biochemical Pharmaceuticals, Pfizer Inc., Chugai Pharmaceutical and Dragon Pharma.
Products Covered:
-Biosimilars
-Epoetin-Alfa
-Epoetin-Beta
-Darbepoietin-Alfa
-Other Biosimilar Products
-Biologics
-Epoetin-Zeta
-Epoetin-Omega
-Other Biologic Products
Drugs Covered:
-Biosimilar Drug
-Xue Da Sheng
-HEMAX
-Abseamed
-Retacrit
-Epoetin-alfa BS
-EPIAO
-Binocrit
-Other Biosimilar Drugs
-Biologic Drug
-Aranesp
-Mircera
-Procrit
-NeoRecromon
-Eprex
-Epogen
-Other Biologic Drugs
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001716562/sample
Applications Covered:
-Anemia
-HIV
-End Stage Renal Disease
-Cancer
-Dialysis
-Oncology Diseases
-Other Applications
End Users Covered:
-Retail Pharmacies
-Hospital
-Other End Users
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Company Profiling
11.1 Johnson and Johnson
11.2 Hospira, Inc.
11.3 F. Hoffmann-La Roche AG
11.4 Amgen Inc
11.5 Kyowa Hakko Kirin Co., Ltd
11.6 3SBio Inc.
11.7 Boehringer Ingelheim Pharmaceuticals, Inc.
11.8 Intas Pharmaceuticals
11.9 Dr. Reddy's Laboratories
11.10 Teva Pharmaceutical Industries
11.11 JCR Pharmaceuticals
11.12 LG Life Science
11.13 Novartis AG
11.14 Shenyang Sunshine Pharmaceutical
11.15 Sihuan Pharmaceutical
11.16 Uni-Bio Science
11.17 Wanbang Biochemical Pharmaceuticals
11.18 Pfizer Inc.
11.19 Chugai Pharmaceutical
11.20 Dragon Pharma
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001716562/buying
For more information about this report: http://www.reportsweb.com/erythropoietin-drug-global-market-outlook-2016-2022
By Application, anemia segment leads the Erythropoietin Drugs market during the forecast period. On the other hand, retail pharmacies in end user segment dominated the global market with a huge market share. In terms of geography, Europe commanded the maximum market share and will continue to dominate the market over the forecast period.
Some of the key players in the market include Johnson and Johnson, Hospira, Inc., F. Hoffmann-La Roche AG, Amgen Inc, Kyowa Hakko Kirin Co., Ltd, 3SBio Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Intas Pharmaceuticals, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries, JCR Pharmaceuticals, LG Life Science, Novartis AG, Shenyang Sunshine Pharmaceutical, Sihuan Pharmaceutical, Uni-Bio Science, Wanbang Biochemical Pharmaceuticals, Pfizer Inc., Chugai Pharmaceutical and Dragon Pharma.
Products Covered:
-Biosimilars
-Epoetin-Alfa
-Epoetin-Beta
-Darbepoietin-Alfa
-Other Biosimilar Products
-Biologics
-Epoetin-Zeta
-Epoetin-Omega
-Other Biologic Products
Drugs Covered:
-Biosimilar Drug
-Xue Da Sheng
-HEMAX
-Abseamed
-Retacrit
-Epoetin-alfa BS
-EPIAO
-Binocrit
-Other Biosimilar Drugs
-Biologic Drug
-Aranesp
-Mircera
-Procrit
-NeoRecromon
-Eprex
-Epogen
-Other Biologic Drugs
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001716562/sample
Applications Covered:
-Anemia
-HIV
-End Stage Renal Disease
-Cancer
-Dialysis
-Oncology Diseases
-Other Applications
End Users Covered:
-Retail Pharmacies
-Hospital
-Other End Users
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Company Profiling
11.1 Johnson and Johnson
11.2 Hospira, Inc.
11.3 F. Hoffmann-La Roche AG
11.4 Amgen Inc
11.5 Kyowa Hakko Kirin Co., Ltd
11.6 3SBio Inc.
11.7 Boehringer Ingelheim Pharmaceuticals, Inc.
11.8 Intas Pharmaceuticals
11.9 Dr. Reddy's Laboratories
11.10 Teva Pharmaceutical Industries
11.11 JCR Pharmaceuticals
11.12 LG Life Science
11.13 Novartis AG
11.14 Shenyang Sunshine Pharmaceutical
11.15 Sihuan Pharmaceutical
11.16 Uni-Bio Science
11.17 Wanbang Biochemical Pharmaceuticals
11.18 Pfizer Inc.
11.19 Chugai Pharmaceutical
11.20 Dragon Pharma
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001716562/buying
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results